ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ: ORIC
· Real-Time Price · USD
9.72
-0.21 (-2.11%)
At close: Aug 15, 2025, 3:59 PM
9.62
-1.03%
After-hours: Aug 15, 2025, 07:13 PM EDT
-2.11% (1D)
| Bid | 9.62 |
| Market Cap | 944.04M |
| Revenue (ttm) | 533K |
| Net Income (ttm) | -132.86M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -5.14 |
| Forward PE | -5.31 |
| Analyst | Buy |
| Ask | 10.07 |
| Volume | 534,402 |
| Avg. Volume (20D) | 1,387,651 |
| Open | 10.04 |
| Previous Close | 9.93 |
| Day's Range | 9.54 - 10.06 |
| 52-Week Range | 3.90 - 14.67 |
| Beta | 1.69 |
About ORIC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORIC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORIC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+33.5%
Oric Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+3.29%
ORIC Pharmaceuticals shares are trading higher after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.
